Neglected Diseases

 As a result, pharmaceutical companies have little interest in working to find a cure for these diseases.  Stimulating awareness about the urgent need for new, better treatment and tests for diseases like leishmaniasis, sleeping sickness and Chagas and noma  is key to the work of MSF’s Access Campaign and the Drugs for Neglected Diseases Initiative (DNDi) of which MSF was a founding partner.